Anzeige
Mehr »
Login
Sonntag, 07.03.2021 Börsentäglich über 12.000 News von 657 internationalen Medien
Bam Bam Resources und die Mega-Kupferlagerstätte in Teslas Hinterhof!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2APAB ISIN: SE0008348262 Ticker-Symbol: 5JD 
München
05.03.21
10:06 Uhr
3,130 Euro
+0,370
+13,41 %
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
EXPRES2ION BIOTECH HOLDING AB Chart 1 Jahr
5-Tage-Chart
EXPRES2ION BIOTECH HOLDING AB 5-Tage-Chart

Aktuelle News zur EXPRES2ION BIOTECH Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DoEXPRES2ION BIOTECHNOLOGIES: ExpreS2ion will participate at key industry and investor events in March 20214
25.02.EXPRES2ION BIOTECHNOLOGIES: ExpreS2ion Announces 2020 Fourth Quarter and Full-Year Results2
EXPRES2ION BIOTECH Aktie jetzt für 0€ handeln
23.02.EXPRES2ION BIOTECHNOLOGIES: ExpreS2ion and University of Bologna announce research collaboration to test HER2-cVLP in state-of-the-art breast cancer mice models3
10.02.EXPRES2ION BIOTECHNOLOGIES: ExpreS2ion's CEO in interview on achievements in 2020 and the company's outlook for 202110
02.02.EXPRES2ION BIOTECHNOLOGIES: ExpreS2ion granted exclusive global license for HER2-cVLP breast cancer vaccine programme from AdaptVac5
27.01.EXPRES2ION BIOTECHNOLOGIES: Analysguiden announces new research report with the target price for ExpreS2ion at 24 SEK per share4
12.01.EXPRES2ION BIOTECHNOLOGIES: Strong preclinical immunization data for the ABNCoV2 cVLP-based COVID-19 vaccine published in Nature Communications3
11.01.EXPRES2ION BIOTECHNOLOGIES: ExpreS2ion strengthens its organization to further accelerate its pipeline project development3
08.01.EXPRES2ION BIOTECHNOLOGIES: ExpreS2ion announces submission of the COUGH-1 clinical trial application by the Prevent-nCoV consortium and Bavarian Nordic to review ABNCoV210
17.12.20EXPRES2ION BIOTECHNOLOGIES: ExpreS2ion publishes filmed scientific interview on the cVLP COVID-19 vaccine development1
27.11.20EXPRES2ION BIOTECHNOLOGIES: ExpreS2ion carries out new share issue for loan conversion1
19.11.20EXPRES2ION BIOTECHNOLOGIES: ExpreS2ion announces interim results for the first nine months of 20202
16.11.20EXPRES2ION BIOTECHNOLOGIES: ExpreS2ion announces successful manufacturing of the cVLP COVID-19 vaccine and further positive updates1
12.11.20Nasdaq Stockholm AB: New equity rights for trading, ExpreS2ion Biotech Holding TO4 and TO5 (506/20)188At the request of ExpreS2ion Biotech Holding AB, ExpreS2ion Biotech Holding AB equity rights TO4 and TO5 will be traded on First North Growth Market as from November 16, 2020. Security name: ExpreS2ion...
► Artikel lesen
12.11.20EXPRES2ION BIOTECHNOLOGIES: First day of trading in warrants of series TO4 and TO51
06.11.20Nasdaq Stockholm AB: Last day of trading in paid subscription units (BTU) of ExpreS2ion Biotech Holding AB (493/20)218Trading in ExpreS2ion Biotech Holding AB paid subscription units is to cease. The last trading day is November 10, 2020. Short name: EXPRS2 BTU ISIN code: SE0014957965 Orderbook ID: 204203 This...
► Artikel lesen
06.11.20EXPRES2ION BIOTECHNOLOGIES: Last day of trading in paid subscribed units (Sw. BTU)2
04.11.20EXPRES2ION BIOTECHNOLOGIES: ExpreS2ion publishes video from COVID-19-focused company presentation at Japanese event2
26.10.20EXPRES2ION BIOTECHNOLOGIES: ExpreS2ion publishes video from company presentation at a Danish investor event3
23.10.20EXPRES2ION BIOTECHNOLOGIES: ExpreS2ion's rights issue oversubscribed2
Seite:  Weiter >>
29 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,2